Your browser does not support iframes.
Carolinas Inc - Local Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
AVEO PHARMA
(NQ:
AVEO
)
2.550
USD
-0.070 (-2.67%)
Streaming Delayed Price
/ Updated:
12:20 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
165,384
Open
2.610
Bid (Size)
2.550 (3400)
Ask (Size)
2.560 (2800)
Prev. Close
2.620
Today's Range
2.550 - 2.660
52wk Range
2.250 - 14.08
Shares Outstanding
51,885,668
Dividend Yield
N/A
Top News
More News
Glancy Binkow & Goldberg Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against AVEO Pharmaceuticals, Inc.
June 17, 2013
from
Business Wire News Releases
Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- AVEO
June 14, 2013
from
GlobeNewswire News Releases
More News
Read More
Law Offices of Todd M. Garber Announces Class Action Lawsuit Against AVEO Pharmaceuticals, Inc.
June 12, 2013
from
Business Wire News Releases
Bio-Wire Equity Surveillance – Closing Bell 6/10/2013
June 10, 2013
category
ACRX
,
MYGN
,
ACAD
, and 4 more.
from
Bio-Wire.Com
FDA rejects Aveo kidney cancer drug, asks for additional trial
June 10, 2013
category
companyNews
from
Reuters: Company News
AVEO Oncology (AVEO) Receives CRL from FDA for Tivozanib
June 10, 2013
from
StreetInsider.com News Articles
AVEO Announces Complete Response Letter Received for Tivozanib New Drug Application in Renal Cell Carcinoma
June 10, 2013
from
Business Wire News Releases
Aveo CEO apologizes, says 140 job cuts ‘necessary’ to move company forward
June 05, 2013
category
Biotech
,
Elan Ezickson
,
Cambridge
, and 5 more.
from
Business Journals
Aveo to slash 62 pct jobs; focus on colon, breast cancer drug
June 04, 2013
category
companyNews
from
Reuters: Company News
AVEO Oncology Announces Strategic Restructuring
June 04, 2013
category
Benzinga
,
News
,
AVEO
from
Latest Articles from Benzinga.com
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.
Your browser does not support iframes.